Benefits in the lipid profile after substitution of abacavir for stavudine: A 48-week prospective studyGARCIA-BENAYAS, Teresa; BLANCO, Francisco; ALCOLEA, Antonio et al.AIDS research and human retroviruses. 2004, Vol 20, Num 12, pp 1289-1292, issn 0889-2229, 4 p.Article

Evaluation of a Systematic Substitution of Zidovudine for Stavudine-Based HAART in a Program Setting in Rural CambodiaISAAKIDIS, Petros; RAGUENAUD, Marie-Eve; PHE, Thong et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 49, Num 1, pp 48-54, issn 1525-4135, 7 p.Article

Rate of thymidine analogue resistance mutation accumulation with zidovudine- or stavudine-based regimensKURITZKES, Daniel R; BASSETT, Roland L; HAZELWOOD, J. Darren et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 1, pp 600-603, issn 1525-4135, 4 p.Article

Real time PCR for rapid determination of susceptibility of adenovirus to antiviral drugsGAINOTTI, Rosana; RICARTE, Carmen; EBEKIAN, Beatriz et al.Journal of virological methods. 2010, Vol 164, Num 1-2, pp 30-34, issn 0166-0934, 5 p.Article

Mitochondrial DNA Subhaplogroups L0a2 and L2a Modify Susceptibility to Peripheral Neuropathy in Malawian Adults on Stavudine Containing Highly Active Antiretroviral TherapyKAMPIRA, Elizabeth; KUMWENDA, Johnstone; VAN OOSTERHOUT, Joep J et al.Journal of acquired immune deficiency syndromes (1999). 2013, Vol 63, Num 5, pp 647-652, issn 1525-4135, 6 p.Article

Benefits and risks of stavudine therapy for HIV-associated neurologic complications in UgandaSACKTOR, N; NAKASUJJA, N; SKOLASKY, R. L et al.Neurology. 2009, Vol 72, Num 2, pp 165-170, issn 0028-3878, 6 p.Article

Isocratic, simultaneous normal-phase LC separation of four impurities for a stavudine synthesis controlKAZOKA, Helena; MADRE, Marina.Talanta (Oxford). 2005, Vol 67, Num 1, pp 98-102, issn 0039-9140, 5 p.Article

Stavudine Concentrations in Women Receiving Postpartum Antiretroviral Treatment and Their Breastfeeding InfantsFOGEL, Jessica M; TAHA, Taha E; ESHLEMAN, Susan H et al.Journal of acquired immune deficiency syndromes (1999). 2012, Vol 60, Num 5, pp 462-465, issn 1525-4135, 4 p.Article

Lipodystrophy and dyslipidemia among patients taking first-line, world health organization-recommended highly active antiretroviral therapy regimens in western IndiaPUJARI, Sanjay N; DRAVID, Ameet; NAIK, Eknath et al.Journal of acquired immune deficiency syndromes (1999). 2005, Vol 39, Num 2, pp 199-202, issn 1525-4135, 4 p.Article

A Longitudinal Study of the Changes in Body Fat and Metabolic Parameters in a South African Population of HIV-Positive Patients Receiving an Antiretroviral Therapeutic Regimen Containing StavudineGEORGE, Jaya A; VENTER, Willem D. F; VAN DEVENTER, Hendrick E et al.AIDS research and human retroviruses. 2009, Vol 25, Num 8, pp 771-781, issn 0889-2229, 11 p.Article

Age and height predict neuropathy risk in patients with HIV prescribed stavudineCHERRY, C. L; AFFANDI, J. S; IMRAN, D et al.Neurology. 2009, Vol 73, Num 4, pp 315-320, issn 0028-3878, 6 p.Article

Efficacy and Safety of Atazanavir, With or Without Ritonavir, as Part of Once-Daily Highly Active Antiretroviral Therapy Regimens in Antiretroviral-Naive PatientsMALAN, D. R; KRANTZ, Edrich; DAVID, Neal et al.Journal of acquired immune deficiency syndromes (1999). 2008, Vol 47, Num 2, pp 161-167, issn 1525-4135, 7 p.Article

Lack of recurrence of hyperlactatemia in HIV-infected patients switched from Stavudine to abacavir or zidovudineLONERGAN, J. Tyler; MCCOMSEY, Grace A; FISHER, Robin L et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 36, Num 4, pp 935-942, issn 1525-4135, 8 p.Article

Pharmacokinetics of coadministered ritonavir-boosted elvitegravir and zidovudine, didanosine, stavudine, or abacavirRAMANATHAN, Srinivasan; GONG SHEN; HINKLE, John et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 46, Num 2, pp 160-166, issn 1525-4135, 7 p.Article

Phenyl phosphoramidate derivatives of stavudine as anti-HIV agents with potent and selective in-vitro antiviral activity against AdenovirusUCKUN, Fatih M; PENDERGRASS, Sharon; QAZI, Sanjive et al.European journal of medicinal chemistry. 2004, Vol 39, Num 3, pp 225-234, issn 0223-5234, 10 p.Article

Prevalence and risk factors for developing K65R mutations among HIV-1 infected patients who fail an initial regimen of fixed-dose combination of stavudine, lamivudine, and nevirapineSUNGKANUPARPH, Somnuek; MANOSUTHI, Weerawat; KIERTIBURANAKUL, Sasisopin et al.Journal of clinical virology. 2008, Vol 41, Num 4, pp 310-313, issn 1386-6532, 4 p.Article

Relation of stavudine discontinuation to anthropometric changes among HIV-infected womenTIEN, Phyllis C; SCHNEIDER, Michael F; COLE, Stephen R et al.Journal of acquired immune deficiency syndromes (1999). 2007, Vol 44, Num 1, pp 43-48, issn 1525-4135, 6 p.Article

Pharmacokinetic evaluation and short-term activity of stavudine, nevirapine, and nelfinavir therapy in HIV-1-infected adultsSKOWRON, Gail; LEOUNG, Gifford; FISHER, Alvan et al.Journal of acquired immune deficiency syndromes (1999). 2004, Vol 35, Num 4, pp 351-358, issn 1525-4135, 8 p.Article

Mechanistic explanation to the variable degradation behaviour of stavudine and zidovudine under hydrolytic, oxidative and photolytic conditionsDUNGE, A; CHAKRABORTI, Asit K; SINGH, Saranjit et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 35, Num 4, pp 965-970, issn 0731-7085, 6 p.Article

Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudineHAVLIR, Diane V; KOELSCH, Kersten K; STRAIN, Matthew C et al.The Journal of infectious diseases. 2005, Vol 191, Num 7, pp 1164-1168, issn 0022-1899, 5 p.Article

Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS clinical trials group protocol 332WADE, Nancy A; UNADKAT, Jashvant D; HITTI, Jane et al.The Journal of infectious diseases. 2004, Vol 190, Num 12, pp 2167-2174, issn 0022-1899, 8 p.Article

Macrocytosis in patients on stavudineEYER-SILVA, Walter A; ARABE, Jucara; PINTO, Jorge Francisco C et al.Scandinavian journal of infectious diseases. 2001, Vol 33, Num 3, pp 239-240, issn 0036-5548Article

Direct transport of 2', 3'-didehydro-3'-deoxythymidine (D4T) and its ester derivatives to the cerebrospinal fluid via the nasal mucous membrane in ratsYAJIMA, T; JUNI, K; SANEYOSHI, M et al.Biological & pharmaceutical bulletin. 1998, Vol 21, Num 3, pp 272-277, issn 0918-6158Article

EFFECTIVENESS OF FIXED-DOSE COMBINATION STAVUDINE, LAMIVUDINE AND NEVIRAPINE (GPO-VIR) FOR TREATMENT OF NAIVE HIV PATIENTS IN THAILAND: A 3-YEAR FOLLOW-UPDESAKORN, Varunee; MAN KARMACHARYA, Biraj; THANACHARTWET, Vipa et al.Southeast Asian journal of tropical medicine and public health. 2011, Vol 42, Num 6, pp 1414-1422, issn 0125-1562, 9 p.Article

Long-term results of initial therapy with abacavir and lamivudine combined with efavirenz, amprenavir/ritonavir, or stavudineBARTLETT, John A; JOHNSON, Judy; HERRERA, Gisela et al.Journal of acquired immune deficiency syndromes (1999). 2006, Vol 43, Num 3, pp 284-292, issn 1525-4135, 9 p.Article